| Filed On | Filing |
|---|---|
| 17 Jan 2019 |
Form 4/A: Van Naarden Jacob, Chief Operating Officer
Received 1,541 shares by exercise or conversion ($5.62K) |
| 17 Jan 2019 |
Form 4/A: Bilenker Joshua H., Director
Received 7,500 shares by exercise or conversion ($8.88K) |
| 07 Aug 2014 |
Form 4/A: Array Biopharma Inc, 10% owner
Received 1,609,560 shares by conversion |
Loading...
